BioPharm International, October 2009 Issue (PDF)
Implementing Toyota’s LEAN Systems in Bioprocessing
Biotech Remains Upbeat During the Summer
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
Biopharmaceuticals: Approval Trends in 2008
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
Harvesting the Benefits of LEAN in Biopharmaceutical Manufacturing
A step-by-step approach is essential for successful implementation.
A Closer Look at Automated In-Line Dilution
Automated in-line dilution can help solve capacity, financial, and quality concerns that biopharmaceutical manufacturing plants may be facing.
Pharma and Healthcare Reform, Part 2
It seems clear that insuring the roughly 46 million Americans who are now uninsured will increase drug sales.
Apply the "Butterfly Effect" to Streamline Your Supply Chain
Small changes can have a big effect further downstream in your manufacturing processes.
Building a Turnkey Manufacturing Solution
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
FDA Leaders Stress Science and Compliance
Stiffer enforcement of quality standards aims to restore public confidence in agency actions.
